MAPT and Mental deterioration: Post-mortem analyses indicate that higher BDNF expression levels, as measured in regions such as the dorsolateral prefrontal cortex (DLPFC), are associated with significantly slower rates of cognitive decline and a reduced burden of amyloid and tau pathology across multiple cortical regions [135].